Diligence memo · auto-generated · as of July 2, 2026

VitruvianMD

VitruvianMD: limited disclosed financing to assess.

Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.

Businessfiled

VitruvianMD operates in AI / ML, based in Africa. OLYMPUS DIGITAL CAMERA SA e-health VitruvianMD raises 8-figure ZAR funding round 0 By Tom Jackson on August 20, 2021 News , Southern Africa South African e-health startup VitruvianMD has raised an eight-figure ZAR – so at least ZAR10 million (US$659,000) – funding round in order to scale its tech and launch more pilots. Founded last year, VitruvianMD combines biomedical engineering and state-of-the-art artificial intelligence (AI) to deliver affordable, high-accuracy diagnostic tools for medical laboratories, with a particular focus on servicing emerging markets.

Sub-sector tags: ai/ml.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

VitruvianMD has raised — in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Most recent recorded round closed around 2021-08-20.

Valuation (modeled)modeled

No modeled valuation — too little disclosed financing to estimate one.

Financing rhythm & timingmixed

Not enough dated financing history to read a financing rhythm.

Comparablesmixed

Capital scale ranks ahead of 62% of AI / ML peers (2067 compared).

Modeled value ranks above 62% of those peers.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.